Arteris, Inc. (NASDAQ:AIP – Get Free Report) CEO K Charles Janac sold 8,432 shares of the company’s stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $12.34, for a total transaction of $104,050.88. Following the completion of the sale, the chief executive officer now directly owns 260,088 shares of the company’s stock, valued at approximately $3,209,485.92. This trade represents a 3.14 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.
K Charles Janac also recently made the following trade(s):
- On Thursday, January 2nd, K Charles Janac sold 6,256 shares of Arteris stock. The shares were sold at an average price of $11.41, for a total transaction of $71,380.96.
- On Monday, December 30th, K Charles Janac sold 58,212 shares of Arteris stock. The shares were sold at an average price of $10.33, for a total transaction of $601,329.96.
- On Thursday, December 26th, K Charles Janac sold 60,584 shares of Arteris stock. The shares were sold at an average price of $10.42, for a total transaction of $631,285.28.
- On Tuesday, December 17th, K Charles Janac sold 14,180 shares of Arteris stock. The stock was sold at an average price of $10.01, for a total transaction of $141,941.80.
- On Thursday, December 12th, K Charles Janac sold 17,856 shares of Arteris stock. The stock was sold at an average price of $10.12, for a total transaction of $180,702.72.
- On Tuesday, December 3rd, K Charles Janac sold 1,242 shares of Arteris stock. The shares were sold at an average price of $8.58, for a total transaction of $10,656.36.
Arteris Stock Performance
Shares of AIP stock opened at $11.25 on Friday. The company’s 50-day moving average price is $9.25 and its 200-day moving average price is $8.15. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 0.30. The stock has a market cap of $451.99 million, a price-to-earnings ratio of -11.72 and a beta of 1.17. Arteris, Inc. has a twelve month low of $4.83 and a twelve month high of $12.64.
Wall Street Analyst Weigh In
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently modified their holdings of the company. US Bancorp DE acquired a new position in shares of Arteris during the 3rd quarter valued at about $34,000. The Manufacturers Life Insurance Company purchased a new stake in Arteris during the second quarter worth about $86,000. Algert Global LLC purchased a new stake in Arteris during the second quarter worth about $115,000. MetLife Investment Management LLC increased its stake in shares of Arteris by 129.1% during the third quarter. MetLife Investment Management LLC now owns 16,951 shares of the company’s stock worth $131,000 after buying an additional 9,551 shares during the period. Finally, Dynamic Technology Lab Private Ltd purchased a new stake in shares of Arteris during the third quarter worth approximately $226,000. Institutional investors and hedge funds own 64.36% of the company’s stock.
Arteris Company Profile
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
Featured Stories
- Five stocks we like better than Arteris
- 3 Warren Buffett Stocks to Buy Now
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- What Are Trending Stocks? Trending Stocks Explained
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.